JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

JNK Pathway Activation Modulates Acquired Resistance to EGFR/HER2–Targeted Therapies

Cancer Res (2016) 76 (18): 5219–5228.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Systems approaches to uncovering the contribution of environment-mediated drug resistance

Marc Creixell
Hyuna Kim
Farnaz Mohammadi
Shelly R. Peyton
Aaron S. Meyer

Current Opinion in Solid State and Materials Science (2022) 26 (5): 101005.

JNK Pathway in CNS Pathologies

Teresa de los Reyes Corrales
María Losada-Pérez
Sergio Casas-Tintó

International Journal of Molecular Sciences (2021) 22 (8): 3883.

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer

Kyu Sic You
Yong Weon Yi
Jeonghee Cho
Jeong-Soo Park
Yeon-Sun Seong

Pharmaceuticals (2021) 14 (6): 589.

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

K. Hoyer
R. Hablesreiter
Y. Inoue
K. Yoshida
F. Briest
F. Christen
N. Kakiuchi
T. Yoshizato
Y. Shiozawa
Y. Shiraishi
J.K. Striefler
S. Bischoff
P. Lohneis
H. Putter
O. Blau
U. Keilholz
L. Bullinger
U. Pelzer
M. Hummel
H. Riess
S. Ogawa
M. Sinn
F. Damm

EBioMedicine (2021) 66: 103327.

Generating kinetic environments to study dynamic cellular processes in single cells

Alexander Thiemicke
Hossein Jashnsaz
Guoliang Li
Gregor Neuert

Scientific Reports (2019) 9 (1)

miR-342-5p as a Potential Regulator of HER2 Breast Cancer Cell Growth

Evita Maria Lindholm
Suvi-Katri Leivonen
Eldri Undlien
Daniel Nebdal
Anna Git
Carlos Caldas
Anne-Lise Børresen-Dale
Kristine Kleivi

MicroRNA (2019) 8 (2): 155.

Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration

Marta Portela
Varun Venkataramani
Natasha Fahey-Lozano
Esther Seco
Maria Losada-Perez
Frank Winkler
Sergio Casas-Tintó
Jeremy N Rich

PLOS Biology (2019) 17 (12): e3000545.

89Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma

Raquel Benedetto
Adriana V.F. Massicano
Bryant K. Crenshaw
Renato Oliveira
Rui M. Reis
Elaine B. Araújo
Suzanne E. Lapi

Cancer Biotherapy and Radiopharmaceuticals (2019) 34 (5): 288.

Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells

Sumit Bhattacharyya
Leo Feferman
Xiaorui Han
Yilan Ouyang
Fuming Zhang
Robert J. Linhardt
Joanne K. Tobacman

Journal of Biological Chemistry (2018) 293 (28): 11076.

The c-Jun N-terminal kinase prevents oxidative stress induced by UV and thermal stresses in corals and human cells

Lucile Courtial
Vincent Picco
Renaud Grover
Yann Cormerais
Cécile Rottier
Antoine Labbe
Gilles Pagès
Christine Ferrier-Pagès

Scientific Reports (2017) 7 (1)

A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance

Alyssa D. Schwartz
Lauren E. Barney
Lauren E. Jansen
Thuy V. Nguyen
Christopher L. Hall
Aaron S. Meyer
Shelly R. Peyton

Integrative Biology (2017) 9 (12): 912.

JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines

Kian Kani
Carolina Garri
Katrin Tiemann
Paymaneh D. Malihi
Vasu Punj
Anthony L. Nguyen
Janet Lee
Lindsey D. Hughes
Ruth M. Alvarez
Damien M. Wood
Ah Young Joo
Jonathan E. Katz
David B. Agus
Parag Mallick

Molecular Cancer Therapeutics (2017) 16 (8): 1645.